Industry News

CVS to Buy Omnicare for $12.7 Billion

Get the Results of the HEOR & Market Access 2015 Salary Survey Now!

Why Are Americans Afraid to Discuss Cost With Their Doctor?

The Difference Between Health and Subjective Well-Being

inventive Health Expands Global Regulatory and Compliance Services

Hepatitis C Drugs Added to WHO List of Essential Medications

Pharmaceuticals and Shadow Pricing a.k.a. Highway Robbery

Ten Case Studies on When FDAMA Section 114 Applies

Drug Company Promotion of Real-World Data in the 21st Century

Who was David Sackett and How Did His Vision Change Modern Medicine?

FDA Places Benefit-Risk Assessment at the Center of the Approval Process

2012 Survey Results on Earnings and Consulting Income of US Health Economists

KOL Engagement and Advisory Boards Summit – Download Available

How do Employers See the Difference Between Specialty and Retail Pharmacy?

What do You Need Right Now to Maximize Your Company’s Pricing and Access in Emerging Markets?

ISPOR Call for Abstract/Proposal Reviewers

Will Aetna Merger Take Place with Cigna or Humana?

Email Marketing is Not Dead! Follow These Tips Success

AMCP CEO Speaks Out About Government Price Negotiations of Pharmaceuticals

Call for Posters at AMCP Nexus 2015 is Now Open!

Want to Know More About Evidence-Based Medicine?

Good Health is Much More Than Not Being Dead

How Real is American Healthcare?

NASP 2015 Annual Meeting and Expo Program Announced

Compounded Drugs to Face Stricter Screening for US Military

How Important Are Risk Thresholds to a Risk-Based Monitoring Plan?

Who Determines Which New Pharmaceutical Products You Will Have Access to?

Apple Has People Excited to Sign Up for Research

Will New York’s Transparency Law Protect Consumers From Health Plan Cost Issues?

Global Oncology Trend Report 2015


Stay Connected